Bio Treatmenst Flashcards

1
Q

What types of medications are used for biological treatments of obsessive-compulsive disorder?

A

SSRIs, tricyclics, monoamine oxidase inhibitors (MAOIs)

These medications are designed to increase monoamine neurotransmitters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How are most medications for OCD administered?

A

Orally as tablets

This is the common method for administering biological treatments for OCD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the typical time lag for noticing improvement with antidepressants for OCD?

A

Up to 12 weeks

Patients usually do not notice any improvement initially.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How long do people generally need to stay on medication to prevent relapse?

A

At least one year

This duration is necessary to effectively manage OCD symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What may be necessary as an alternative to ceasing medication completely?

A

A maintenance dose

This helps in managing symptoms without stopping medication abruptly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is it important to manage the dosage of OCD medications carefully?

A

To prevent unpleasant withdrawal symptoms

Some drugs can lead to withdrawal if ceased too quickly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What neurotransmitters do tricyclics increase?

A

Serotonin, dopamine, noradrenaline

These neurotransmitters play a role in mood regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What was the name of the tricyclic drug prescribed to Charles in the case study?

A

Clomipramine

This drug had a significant impact on Charles’s daily functioning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How quickly did clomipramine impact Charles’s daily functioning?

A

Within just four weeks

This allowed him to perform tasks he previously could not due to OCD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What symptom was Charles struggling with that affected his daily activities?

A

Obsession with stickiness

He perceived stickiness as a ‘disease’.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happened to Charles’s response to clomipramine over time?

A

He built up a tolerance

This led to the drug no longer being effective for him.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How did Charles’s OCD symptoms manifest after building a tolerance to the drug?

A

Symptoms returned in a more manageable way

This allowed him to function relatively well during the school day.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do SSRIs do in the synapse?

A

SSRIs increase serotonin in the synapse by blocking presynaptic transporter molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is the exact mode of action for SSRIs clear?

A

No, the exact mode of action for these drugs is still unclear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens to symptoms when SSRIs are used?

A

Improvement in symptoms is often not observed for some considerable time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What might cause the improvement in symptoms after using SSRIs?

A

Improvement may result from down regulation, where the brain compensates for increased serotonin.

17
Q

How might serotonin levels affect other neurochemicals?

A

Serotonin levels may regulate the release of other neurochemicals, triggering a reduction in symptoms.

18
Q

What is one way to enhance the effects of SSRIs in treatment-resistant patients?

A

By offering additional drugs, such as risperidone (an atypical antipsychotic).

19
Q

What percentage of patients showed clinical effectiveness with SSRIs and risperidone?

A

72 per cent of patients showed clinical effectiveness.

20
Q

What reduction in Y-BOCS scores indicates effectiveness of the SSRI and risperidone combination?

A

A reduction of at least 35 per cent in Y-BOCS scores.

21
Q

What is granisetron?

A

Granisetron is a serotonin antagonist that blocks serotonin receptors.

22
Q

What combination achieved a 100 per cent effectiveness?

A

A combination of an SSRI and granisetron.

23
Q

Fill in the blank: SSRIs increase serotonin in the synapse by blocking _______ molecules.

A

presynaptic transporter

24
Q

What was the success rate in the study by Askari et al. (2012)?

A

100 cent success rate

The specific percentage is not provided in the text, but it indicates a high level of success.

25
Q

By what percentage did all patients improve on the Y-BOCS?

A

35 per cent

Y-BOCS stands for Yale-Brown Obsessive Compulsive Scale, a measure used to assess the severity of obsessive-compulsive disorder.

26
Q

What percentage of patients were symptom-free after two months?

A

90 per cent

Indicates a significant positive outcome from the biological treatments administered.

27
Q

What do the results of the study demonstrate about biological treatments?

A

They can have a remarkable impact if the correct combinations can be found

Highlights the importance of personalized treatment approaches.

28
Q

What must be put in place to support individuals undergoing biological treatments?

A

Measures to support the individual with potential side effects

Addresses the need for monitoring and managing side effects during treatment.

29
Q

What is a strength of SSRIs in treating OCD?

A

Their use is supported by research evidence indicating that the impact is not simply a placebo effect.

For example, a meta-analysis of 17 randomized control trials found significantly greater improvement in patients’ symptoms in treatment groups compared to placebo.

30
Q

What did Issari et al. (2016) find regarding SSRIs?

A

They found that the amount of relief provided by SSRIs appeared to diminish over time, but this was moderated by offering higher dosages.

31
Q

What is a practical weakness of SSRIs?

A

They can lead to unpleasant side effects such as constipation, diarrhoea, nausea, vomiting, headaches, dizziness, anxiety, and sleep problems.

32
Q

What issue can arise from the side effects of SSRIs?

A

They can lead to non-compliance, meaning people may not take their medication.

33
Q

What percentage of people report no improvement in symptoms after standard drug treatments for OCD?

A

Up to 60 percent report no improvement.

(McDougle et al., 1993)

34
Q

What is the typical reduction in symptom severity for those who do experience relief from SSRIs?

A

The reduction may only be between 20 and 30 percent.

(Pigott and Seay, 1999)

35
Q

What does the polygenic nature of OCD imply for future treatments?

A

It suggests that medicine may become more personalized, allowing doctors to tailor treatments based on the unique combinations of genes influencing each patient’s symptoms.

36
Q

What is critical to the success of biological treatments for OCD?

A

Situational factors, such as the quality of the therapeutic alliance between doctors and patients, impact the effectiveness of the treatment.